Hindustan Bio Sciences Ltd vs Par Drugs Chemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Hindustan Bio Sciences Ltd is ₹ 9.06 as of 30 Apr 15:30 . The P/E Ratio of Hindustan Bio Sciences Ltd changed from 120.8 on March 2024 to 69.8 on March 2025 . This represents a CAGR of -23.99% over 2 yearsThe P/E Ratio of Par Drugs & Chemicals Ltd changed from 6.6 on March 2021 to 7.8 on March 2025 . This represents a CAGR of 3.40% over 5 years The Market Cap of Hindustan Bio Sciences Ltd changed from ₹ 15.38 crore on March 2021 to ₹ 7.16 crore on March 2025 . This represents a CAGR of -14.18% over 5 yearsThe Market Cap of Par Drugs & Chemicals Ltd changed from ₹ 76.17 crore on March 2021 to ₹ 104.5 crore on March 2025 . This represents a CAGR of 6.53% over 5 years The revenue of Hindustan Bio Sciences Ltd for the Dec '25 is ₹ 0.4 crore as compare to the Sep '25 revenue of ₹ 0.01 crore. This represent the growth of 3900% The revenue of Par Drugs & Chemicals Ltd for the Dec '25 is ₹ 30.67 crore as compare to the Sep '25 revenue of ₹ 29.14 crore. This represent the growth of 5.25% The ebitda of Hindustan Bio Sciences Ltd for the Dec '25 is ₹ 0.09 crore as compare to the Sep '25 ebitda of ₹ -0.05 crore. This represent the decline of -280% The ebitda of Par Drugs & Chemicals Ltd for the Dec '25 is ₹ 7.39 crore as compare to the Sep '25 ebitda of ₹ 6.55 crore. This represent the growth of 12.82% The net profit of Hindustan Bio Sciences Ltd changed from ₹ 0.08 crore to ₹ 0.08 crore over 7 quarters. This represents a CAGR of 0.00% The net profit of Par Drugs & Chemicals Ltd changed from ₹ 2.53 crore to ₹ 4.8 crore over 7 quarters. This represents a CAGR of 44.19% The Dividend Payout of Hindustan Bio Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Par Drugs & Chemicals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Hindustan Bio Sciences Ltd

Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991.
The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors.
The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates. Previously, it was engaged in cement manufacturing and due to sluggish in the industry the company diversified its business into Bio Technology & Pharmaceuticals activities and the name of the Company was changed from Garuda Cements to Hindustan Bio-Sciences Ltd. In 2001, it diversified into software field and subsequently changed its name to Hindustan Softel Limited which presently got changed into Hindustan Bio Sciences Ltd.

About Par Drugs & Chemicals Ltd

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat on 26 February 1999.
Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. The Company began in 1982 under the vision of the founder, Late Shri Vallabhbhai J. Savani.
The Company discontinued its existing pharmaceutical and chemical operations and diversified into an entirely new vertical line of business.
With shareholder approval, the Company is investing in real estate & construction, clean & renewable energy, and capital markets. At present, Company is engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets.

FAQs for the comparison of Hindustan Bio Sciences Ltd and Par Drugs & Chemicals Ltd

Which company has a larger market capitalization, Hindustan Bio Sciences Ltd or Par Drugs & Chemicals Ltd?

Market cap of Hindustan Bio Sciences Ltd is 9 Cr while Market cap of Par Drugs & Chemicals Ltd is 111 Cr

What are the key factors driving the stock performance of Hindustan Bio Sciences Ltd and Par Drugs & Chemicals Ltd?

The stock performance of Hindustan Bio Sciences Ltd and Par Drugs & Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hindustan Bio Sciences Ltd and Par Drugs & Chemicals Ltd?

As of May 4, 2026, the Hindustan Bio Sciences Ltd stock price is INR ₹9.06. On the other hand, Par Drugs & Chemicals Ltd stock price is INR ₹90.83.

How do dividend payouts of Hindustan Bio Sciences Ltd and Par Drugs & Chemicals Ltd compare?

To compare the dividend payouts of Hindustan Bio Sciences Ltd and Par Drugs & Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.